Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
editorial
. 1979 Feb 24;1(6162):505–506.

Alopecia areata.

PMCID: PMC1598014  PMID: 87235

Full text

PDF
505

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betterle C., Peserico A., Del Prete G., Trisotto A. Letter: Autoantibodies in alopecia areata. Arch Dermatol. 1975 Jul;111(7):927–928. [PubMed] [Google Scholar]
  2. Burton J. L., Shuster S. Large doses of glucocorticoid in the treatment of alopecia areata. Acta Derm Venereol. 1975;55(6):493–496. [PubMed] [Google Scholar]
  3. Carter D. M., Jegasothy B. V. Alopecia areata and Down syndrome. Arch Dermatol. 1976 Oct;112(10):1397–1399. [PubMed] [Google Scholar]
  4. Cochran R. E., Thomson J., MacSween R. N. An auto-antibody profile in alopecia totalis and diffuse alopecia. Br J Dermatol. 1976 Jul;95(1):61–65. [PubMed] [Google Scholar]
  5. Cunliffe W. J., Hall R., Stevenson C. J., Weightman D. Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol. 1969 Dec;81(12):877–881. doi: 10.1111/j.1365-2133.1969.tb15967.x. [DOI] [PubMed] [Google Scholar]
  6. Daman L. A., Rosenberg E. W., Drake L. Treatment of alopecia areata with dinitrochlorobenzene. Arch Dermatol. 1978 Jul;114(7):1036–1038. [PubMed] [Google Scholar]
  7. Du Vivier A., Munro D. D. Alopecia areata, autoimmunity, and Down's syndrome. Br Med J. 1975 Jan 25;1(5951):191–192. doi: 10.1136/bmj.1.5951.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Frentz G., Eriksen K. Treatment of alopecia areata with DNCB--an immunostimulation? Acta Derm Venereol. 1977;57(4):370–371. [PubMed] [Google Scholar]
  9. Happle R., Echternacht K. Induction of hair growth in alopecia areata with D.N.C.B. Lancet. 1977 Nov 12;2(8046):1002–1003. doi: 10.1016/s0140-6736(77)92896-3. [DOI] [PubMed] [Google Scholar]
  10. Hertz K. C., Gazze L. A., Kirkpatrick C. H., Katz S. I. Autoimmune vitiligo: detection of antibodies to melanin-producing cells. N Engl J Med. 1977 Sep 22;297(12):634–637. doi: 10.1056/NEJM197709222971204. [DOI] [PubMed] [Google Scholar]
  11. Kern F., Hoffman W. H., Hambrick G. W., Jr, Blizzard R. M. Alopecia areata. Immunologic studies and treatment with prednisone. Arch Dermatol. 1973 Mar;107(3):407–412. doi: 10.1001/archderm.107.3.407. [DOI] [PubMed] [Google Scholar]
  12. Klaber M. R., Munro D. D. Alopecia areata: immunofluorescence and other studies. Br J Dermatol. 1978 Oct;99(4):383–386. doi: 10.1111/j.1365-2133.1978.tb06174.x. [DOI] [PubMed] [Google Scholar]
  13. Lendrum R., Walker G., Cudworth A. G., Theophanides C., Pyke D. A., Bloom A., Gamble D. R. Islet-cell antibodies in diabetes mellitus. Lancet. 1976 Dec 11;2(7998):1273–1276. doi: 10.1016/s0140-6736(76)92033-x. [DOI] [PubMed] [Google Scholar]
  14. MULLER S. A., WINKELMANN R. K. ALOPECIA AREATA. AN EVALUATION OF 736 PATIENTS. Arch Dermatol. 1963 Sep;88:290–297. doi: 10.1001/archderm.1963.01590210048007. [DOI] [PubMed] [Google Scholar]
  15. Main R. A., Robbie R. B., Gray E. S., Donald D., Horne C. H. Smooth muscle antibodies and alopecia areata. Br J Dermatol. 1975 Apr;92(4):389–393. doi: 10.1111/j.1365-2133.1975.tb03098.x. [DOI] [PubMed] [Google Scholar]
  16. Porter D., Burton J. L. A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata. Br J Dermatol. 1971 Sep;85(3):272–273. doi: 10.1111/j.1365-2133.1971.tb07230.x. [DOI] [PubMed] [Google Scholar]
  17. Tofahrn J., Gernand E., Hundeiker M. Sulfontherapie bei Alopecia areata. Z Hautkr. 1976 Dec 1;51(23):989–992. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES